Extra! Extra!
We’re driving the conversation around the personal genome revolution, and people are starting to take notice. Read what some of the world’s finest publications have said about us, and check back to see who will write about us next.
MICROSOFT BLOG – OCTOBER 11, 2019
Powering genomics tools and analysis with cloud computing
CNBC – JULY 1, 2019
23andMe competitor Veritas Genetics slashes price of whole genome sequencing 40% to $600
ONEZERO BY MEDIUM – JULY 1, 2019
You Can Now Get Your Whole Genome Sequenced for Less Than an iPhone
TECH CRUNCH – AUGUST 29, 2018
George Church’s genetics on the blockchain startup just raised $4.3 million from Khosla
CNBC – AUGUST 19, 2018
Veritas is studying the DNA of people who live to 110, looking for clues to longevity
HEALTHCARE BIZ INT’L – APRIL 20, 2018
Veritas Genetics: Innovative Low Cost Business Model Winner
CNBC – FEBRUARY 8, 2018
Harvard genetics pioneer wants to monetize DNA with digital currency, and defeat 23andMe
GENOME WEB – JANUARY 8, 2018
Veritas Genetics, Mayo Clinic Partner to Expand Access to WGS
XCONOMY – AUGUST 3, 2017
Veritas Buys Curoverse to Bring A.I. Analysis of Genes to the Masses
ALL THINGS CONSIDERED – JUNE 26, 2017
Routine DNA Sequencing May Be Helpful And Not As Scary As Feared
Want to be up to date with our adventures?
Sign up for our newsletter and join the conversation.
We are a passionate and dynamic group of people driving accessibility to genomics across the globe. Our goal: empower people to live healthier, longer.